Microvascular Remodeling in Development
Microvascular Remodeling in Development
批准号:
7640944
负责人:
LAURA E BENJAMIN
金额:
$42.5万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2012-06-30
关键词:
Applications GrantsBindingBloodBlood VesselsCell NucleusCellsClinicalCollaborationsComputer Systems DevelopmentCongenital AbnormalityCystic LymphangiomaDataDefectDevelopmentDiabetic RetinopathyDiseaseEmbryoEndothelial CellsFamilyFingersFunctional disorderGene ExpressionGene TargetingGeneticGenetic TranscriptionGrowth FactorHomologous GeneHumanInvestigationKnockout MiceKnowledgeLaboratory StudyLiteratureLymphangiogenesisLymphaticMacular degenerationMethodsModelingMolecularMolecular BiologyMonomeric GTP-Binding ProteinsMusNeonatalNuclearPathologic ProcessesPathway interactionsPhenotypePlasmidsPoint MutationPopulationProteinsRegulationRetinalRetinal NeovascularizationRoleSignal PathwaySisterSkinStressTherapeuticTubeVascular DiseasesVascular Endothelial Growth Factor ReceptorVascular SystemWound HealingZinc Fingersangiogenesisdiabetic wound healingdosagepromoterpublic health relevancereceptorresponseretinal angiogenesisrhotraffickingtranscription factortrend
中文摘要
描述(由申请人提供):这项建议的重点是RhoB在血管和淋巴管生成中的作用。所使用的模型包括新生儿视网膜新生血管和皮肤血管生成以及淋巴管生成。这项赠款申请的总体假设是,RhoB通过调节转录因子DB1/Vezf1的转录活性促进血管内皮细胞表型并抑制淋巴管分化。目的1:确定利用RhoB和DB1/VEZF的血液和淋巴功能为此,我们将完成对RhoB基因缺失小鼠以及RhoB和vezf1杂交小鼠视网膜血管和皮肤血管和淋巴表型的检测。我们还将使淋巴管和血液内皮细胞形成交叉小鼠,并检测对增殖、存活和管子形成的功能影响。目的:探讨RhoB和DB1/VEZF1协同作用对血管内皮细胞基因表达的影响。结果表明,RhoB和DB1(人Vezf1的同源物)对血管内皮细胞中血管内皮生长因子受体的表达有相似的影响,尤其是它们协同调节Nrp1的表达。我们有新的数据表明,我们可以以DB1依赖的方式将Nrp1启动子与RhoB免疫共沉淀,即当我们与野生型DB1而不是具有阻止其与RhoB相互作用的点突变的DB1共转染表达质粒时。这一目的将扩大这些研究,以更充分地了解RhoB和DB1靶基因的共同调控。公共卫生相关性:有些令人惊讶的是,我们在淋巴遗传学和分子生物学方面的知识远远落后于他们的姊妹网络--血管系统。我们的应用计划研究RhoB和DB1用于协作调节视网膜血管生成、皮肤血管生成和淋巴管生成的生物学和分子机制。这些发现的疾病相关性可能会影响糖尿病视网膜病变和黄斑变性等视网膜血管疾病,以及多种环境下的伤口愈合。
英文摘要
DESCRIPTION (provided by applicant): This proposal is focused on the role of RhoB in vascular and lymphatic angiogenesis. The models used include neonatal retinal neovascularization and skin angiogenesis and lymphangiogenesis. The overall hypothesis of this grant application is that RhoB promotes vascular endothelial phenotypes and inhibits lymphatic differentiation by regulating the transcriptional activity of the transcription factor Db1/Vezf1. Aim 1: Determine blood and lymphatic functions that utilize RhoB and Db1/VEZF In this aim we will complete the examination of the retinal vascular and skin vascular and lymphatic phenotypes in RhoB null mice, and rhoB and vezf1 intercrosses. We will also make lymphatic and blood endothelial cells form the intercrossed mice and examine functional effects on proliferation, survival and tube formation. Aim 2: Determine the mechanisms of RhoB and Db1/VEZF1 collaboration on gene expression We show evidence that RhoB and Db1 (human homologue of Vezf1) have similar effects on expression of VEGF receptors in endothelial cells and that they collaborate to regulate expression of Nrp1 in particular. We have new data that we can immunoprecipitate the nrp1 promoter with RhoB in a Db1 dependent manner that is when we co-transfect an expression plasmid with wild type Db1 but not Db1 with a point mutation that blocks its interaction with RhoB. This aim will extend these studies to more fully understand the co-regulation of target genes of RhoB and Db1. PUBLIC HEALTH RELEVANCE: Somewhat surprisingly, our knowledge of lymphatic genetics and molecular biology has lagged significantly behind that of their sister network, the blood vasculature. Our application proposes to study the biology and molecular mechanisms that RhoB and Db1 use to collaborate to regulate retinal angiogenesis and skin angiogenesis and lymphangiogenesis. The disease relevance of these findings could impact both retinal vascular diseases such as diabetic retinopathy and macular degeneration as well as wound healing in multiple settings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VEGFs in tumor lymphatic metastasis
-
批准号:7754556
-
项目类别:
-
资助金额:$45.93万
-
财政年份:2009
-
负责人:LAURA E BENJAMIN
-
依托单位:
Downstream of Akt in the tumor vessel
-
批准号:7647119
-
项目类别:
-
资助金额:$46.0万
-
财政年份:2008
-
负责人:LAURA E BENJAMIN
-
依托单位:
AKT pathway as a therapeutic tumor vessel target
-
批准号:7525417
-
项目类别:
-
资助金额:$38.96万
-
财政年份:2008
-
负责人:LAURA E BENJAMIN
-
依托单位:
Downstream of Akt in the tumor vessel
-
批准号:7825452
-
项目类别:
-
资助金额:$46.92万
-
财政年份:2008
-
负责人:LAURA E BENJAMIN
-
依托单位:
Downstream of Akt in the tumor vessel
-
批准号:7531283
-
项目类别:
-
资助金额:$44.66万
-
财政年份:2008
-
负责人:LAURA E BENJAMIN
-
依托单位:
AKT pathway as a therapeutic tumor vessel target
-
批准号:7644435
-
项目类别:
-
资助金额:$40.23万
-
财政年份:2008
-
负责人:LAURA E BENJAMIN
-
依托单位:
Angiogenesis in Breast Cancer
-
批准号:7544522
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2005
-
负责人:LAURA E BENJAMIN
-
依托单位:
Angiogenesis in Breast Cancer
-
批准号:6875395
-
项目类别:
-
资助金额:$33.58万
-
财政年份:2005
-
负责人:LAURA E BENJAMIN
-
依托单位:
Angiogenesis in Breast Cancer
-
批准号:7001312
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2005
-
负责人:LAURA E BENJAMIN
-
依托单位:
Angiogenesis in Breast Cancer
-
批准号:7161367
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2005
-
负责人:LAURA E BENJAMIN
-
依托单位:
Angiogenesis in Breast Cancer
-
批准号:7336385
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2005
-
负责人:LAURA E BENJAMIN
-
依托单位:
Survival Signaling in Breast Cancer
-
批准号:7457687
-
项目类别:
-
资助金额:$33.04万
-
财政年份:2004
-
负责人:LAURA E BENJAMIN
-
依托单位:
Survival Signaling in Breast Cancer
-
批准号:7115015
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2004
-
负责人:LAURA E BENJAMIN
-
依托单位:
Survival Signaling in Breast Cancer
-
批准号:7245097
-
项目类别:
-
资助金额:$33.04万
-
财政年份:2004
-
负责人:LAURA E BENJAMIN
-
依托单位:
Survival Signaling in Breast Cancer
-
批准号:6945221
-
项目类别:
-
资助金额:$34.85万
-
财政年份:2004
-
负责人:LAURA E BENJAMIN
-
依托单位:
Survival Signaling in Breast Cancer
-
批准号:6812496
-
项目类别:
-
资助金额:$34.85万
-
财政年份:2004
-
负责人:LAURA E BENJAMIN
-
依托单位:
Microvascular remodeling in development
-
批准号:7066041
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2003
-
负责人:LAURA E BENJAMIN
-
依托单位:
Microvascular remodeling in development
-
批准号:6766871
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2003
-
负责人:LAURA E BENJAMIN
-
依托单位:
Microvascular Remodeling in Development
-
批准号:7530603
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2003
-
负责人:LAURA E BENJAMIN
-
依托单位:
Microvascular remodeling in development
-
批准号:6611587
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2003
-
负责人:LAURA E BENJAMIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: